Viewing Study NCT03193866

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:21 PM
Ignite Modification Date: 2026-05-05 @ 9:26 PM
Study NCT ID: NCT03193866
Status: COMPLETED
Last Update Posted: 2025-04-20
First Post: 2017-04-20
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: COMparison Between All immunoTherapies for Multiple Sclerosis.
Sponsor: Karolinska Institutet
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing-remitting Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunomodulating treatment View
None Cohort study View
None Dimethyl fumarate View
None Fingolimod View
None Interferon-beta View
None Natalizumab View
None Rituximab View
None Glatiramer acetate View